Adam Afshar
Directeur/Bestuurslid bij Ariana Pharmaceuticals SA
Profiel
Adam Afshar was the founder of Hyde Park Global Investments LLC, which he founded in 2005 and where he held the titles of President & Chief Executive Officer.
He is currently a Director at Ariana Pharmaceuticals SA. Mr. Afshar obtained an MBA from The University of Chicago.
Actieve functies van Adam Afshar
| Bedrijven | Functie | Begin |
|---|---|---|
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Directeur/Bestuurslid | 12-11-2009 |
Eerdere bekende functies van Adam Afshar
| Bedrijven | Functie | Einde |
|---|---|---|
Hyde Park Global Investments LLC
 Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Algemeen Directeur | - |
Opleiding van Adam Afshar
| The University of Chicago | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Finance |
